2023
1217-P: Willingness to Deintensify in Patients with Type 2 Diabetes—The Diabetes and Aging Study
HAIDER S, PARKER M, HUANG E, GRANT R, MOFFET H, LAITEERAPONG N, LIU J, LIPSKA K, KARTER A. 1217-P: Willingness to Deintensify in Patients with Type 2 Diabetes—The Diabetes and Aging Study. Diabetes 2023, 72 DOI: 10.2337/db23-1217-p.Peer-Reviewed Original ResearchType 2 diabetesOlder patientsKaiser Permanente Northern CaliforniaDe-intensify treatmentDuration of diabetesGlucose-lowering medicationsNumber of medicationsProportion of patientsClinical guideline recommendationsHealth status factorsPoor health statusCross-sectional analysisInsulin useComplex regimensLess medicationGuideline recommendationsPatients' willingnessAbbVie Inc.Side effectsDiabetesPatient experiencePatientsHealth statusHypoglycemia historyMedications
2019
379-P: Changes in Diabetes Management after a Hospital Visit for Severe Hypoglycemia
VIJAYAKUMAR P, LIU S, KAHN P, MCCOY R, KARTER A, LIPSKA K. 379-P: Changes in Diabetes Management after a Hospital Visit for Severe Hypoglycemia. Diabetes 2019, 68 DOI: 10.2337/db19-379-p.Peer-Reviewed Original ResearchSevere hypoglycemic eventsType 2 diabetesDiabetes managementSevere hypoglycemiaHypoglycemic eventsNational InstituteGlucose-lowering medicationsGlucose-lowering therapyProportion of patientsThird of patientsEmergency department visitsPhysician office visitsContinuous glucose monitor useBaseline HbA1cED visitsDepartment visitsHospital admissionKidney diseaseOffice visitsMean ageHospital visitsClinical guidelinesMedication fillsHypoglycemiaDiabetes
2018
High-Risk Medication Use to Achieve Tight Glycemic Control among U.S. Adults with Serious Chronic Conditions
MCCOY R, HOUTEN H, LIPSKA K, SHAH N. High-Risk Medication Use to Achieve Tight Glycemic Control among U.S. Adults with Serious Chronic Conditions. Diabetes 2018, 67 DOI: 10.2337/db18-1652-p.Peer-Reviewed Original ResearchEnd-stage renal diseaseChronic kidney diseaseChronic obstructive pulmonary diseaseMajority of patientsHeart failureMyocardial infarctionSerious comorbiditiesGlycemic controlCerebrovascular diseaseChronic conditionsHigh-risk medication usePlurality of patientsProportion of patientsObstructive pulmonary diseaseStage renal diseaseUse of insulinOptumLabs Data WarehouseTight glycemic controlHigh-risk drugsSerious chronic conditionsMedicare Advantage beneficiariesGlycemic targetsUrinary incontinenceMedication usePeripheral neuropathy